ABSTRACT
INTRODUCTION: Lumbar pain of facet origin is a common problem worldwide. For those patients not responding to traditional treatment, one approach may be intra-articular infiltration of corticoid and anaesthetic. However, despite the increasing demand for this procedure, no consensus exists regarding its therapeutic value. The selection of eligible participants may be a determining factor since only those with an inflammatory process will benefit from the use of corticosteroids. This study aims to identify differences in disability, pain and quality of life scores in individuals with and without facet joint inflammation who were diagnosed using MRI. METHOD AND ANALYSIS: This prospective cohort will include individuals older than 18 years with a clinical diagnosis of facet syndrome who underwent intra-articular infiltration. Changes in scores of pain, disability and quality of life questionnaires at 1, 3, 6 and 12 months of follow-up compared with baseline will be analysed. An MRI examination performed before infiltration will help to distinguish between exposed (with inflammation) and non-exposed (non-inflammation) groups with facet syndrome. The primary outcome will be the disability questionnaire (Roland Morris), and the secondary outcomes will be the score questionnaires for pain (Visual Analogue Scale), quality of life (EuroQol Quality of Life Questionnaire) and disability (Oswestry). ETHICS AND DISSEMINATION: The Internal Review Board approved this study, which started only after the approval number (5291417.0.0000.0071) was received. All recruited participants will receive a verbal explanation about the purpose of the study, and their decision to participate will be free and voluntary. All participants enrolled in the study will provide a signed informed consent form including confidentiality terms. The results obtained in this study will be presented at national and international conferences and published in peer-reviewed scientific journals to disseminate the knowledge. TRIALS REGISTRATION NUMBER: NCT03304730; Pre-results.
Subject(s)
Low Back Pain/drug therapy , Quality of Life , Ropivacaine/administration & dosage , Triamcinolone/administration & dosage , Adult , Anesthetics, Local/administration & dosage , Cohort Studies , Female , Follow-Up Studies , Glucocorticoids/administration & dosage , Humans , Injections, Intra-Articular , Low Back Pain/diagnosis , Magnetic Resonance Imaging , Male , Middle Aged , Pain Measurement , Prognosis , Prospective Studies , Tomography, X-Ray Computed , Zygapophyseal JointABSTRACT
Neste artigo apresentamos os resultados do tratamento de vinte e cinco pacientes com hemiplegia espástica com toxina botulítica tipo A e fenol aquoso 6 por cento.Os procedimentos de neurólise química foram realizados entre os dias 28 e 30 de agosto de 2002. Os pacientes apresentavam idades entre 41 e 73 anos (56 mais ou menos 8,65) sendo 13 homens e 12 mulheres.Os pacientes foram acompanhados durante três meses apresentando melhora clínica e funcional após o tratamento de reabilitaçäo
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Hemiplegia , Botulinum Toxins, Type A/therapeutic use , Muscle SpasticityABSTRACT
The cold compression applied to relief pain in post-operatory orthopedic patient it's commonly used in rehabilitation process particulary in knee surgery.The aim of this research is quantify and standardize the use of criotherapy by continuous circulation compressionsion cold therapy.This tecnique was used in ten patients and the results showed it works on pain relief and increased of move of range of knee
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Cryotherapy , Knee InjuriesABSTRACT
A neurólise química seletiva faz parte do processo reabilitacional na espasticidade de membros superiores dos pacientes hemiplégicos. O objetivo deste trabalhoé apresentar a padronizaçäo da abordagem das vias de acesso em membros superiores de pacientes hemiplégicos para a realizaçäo desta técnica terapêutica